Aldosterone antagonists for people with chronic kidney disease requiring dialysis-Reference-Cited by-同舟云学术

Aldosterone antagonists for people with chronic kidney disease requiring dialysis

Published:2021-02-15 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hasegawa Takeshi¹²,Nishiwaki Hiroki³,Ota Erika⁴,Levack William MM⁵,Noma Hisashi⁶

Affiliation:

1. Showa University Research Administration Center (SURAC); Showa University; Tokyo Japan

2. Division of Nephrology, Department of Medicine, School of Medicine; Showa University; Tokyo Japan

3. Division of Nephrology, Department of Medicine; Showa University Fujigaoka Hospital; Yokohama Japan

4. Global Health Nursing, Graduate School of Nursing Science; St. Luke's International University; Tokyo Japan

5. Rehabilitation Teaching and Research Unit, Department of Medicine; University of Otago; Wellington New Zealand

6. Department of Data Science; The Institute of Statistical Mathematics; Tokyo Japan

Publisher

Wiley

Subject

Pharmacology (medical)

Reference73 articles.

1. Spironolactone is secure and reduces left ventricular hypertrophy in hemodialysis patients;Feniman-De-Stefano;Therapeutic Advances in Cardiovascular Disease,2015

2. Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients;Gross;American Journal of Kidney Diseases,2005

3. Spironolactone prevents cardiac hypertrophy in peritoneal dialysis patients without significant adverse effects [abstract no: SA-OR127];Ito;Journal of the American Society of Nephrology,2013

4. Long-term effects of spironolactone in peritoneal dialysis patients;Ito;Journal of the American Society of Nephrology,2014

5. Long-term effects of low-dose spironolactone on chronic dialysis patients: a randomized placebo-controlled study;Lin;Journal of Clinical Hypertension,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Chronic Heart Failure in Dialysis Patients: A Challenging but Rewarding Path;Reviews in Cardiovascular Medicine;2024-06-25

2. How to delay the progression of chronic kidney disease: focusing on medications;Childhood Kidney Diseases;2024-06-13

3. Another evidence that supports the continued use of RAS inhibitors in end-stage kidney diseases;Hypertension Research;2024-04-24

4. Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials;BMJ Open;2024-03

5. Home-Based Dialysis: A Primer for the Internist;Annual Review of Medicine;2024-01-29